
Ab Flo Caps
LUPIN LAB - capsule - 15 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Medicines with the same active ingredient and strength as Vobit 0.3MG Tab.
You are viewing
Vobit 0.3MG Tab
tablet - 0.3 mg - 15 S
₹357
₹23.77 per tablet
Merck Ltd · tablet - 10 S · Rx
₹53
₹5.25 per tablet
Blue Cross Laboratories Pvt Ltd · tablet - 0.3 mg - 15 S · Rx
₹94
₹6.25 per tablet
Voglibose (0.3mg)
Type 2 diabetes mellitus (as an add-on to diet and exercise), especially for control of post‑meal (postprandial) blood glucose; may be used alone or with other antidiabetic medicines as prescribed.
Voglibose is an alpha‑glucosidase inhibitor that slows down the breakdown and absorption of carbohydrates in the intestine. This reduces the rise in blood sugar levels after meals and improves overall glycaemic control.
Oral tablet. Usually taken just before meals (or with the first bite of food) as prescribed by the doctor. Do not skip meals after taking it; follow diet and exercise advice. If taken with other antidiabetics, monitor blood glucose regularly.
Common side effects of Vobit 0.3MG Tab may include:

LUPIN LAB - capsule - 15 S
Standard delivery
LUPIN LAB - tablet - 10 S
Standard delivery

LUPIN LAB - gel - 20 g
Standard delivery

LUPIN LAB - 10 S
Standard delivery

LUPIN LAB - tablet - 40 mg - 10 S
Standard delivery
LUPIN LAB - tablet - 80 mg - 10 S
Standard delivery

LUPIN LAB - tablet - 10 S
Standard delivery

LUPIN LAB - tablet - 10 S
Standard delivery
SANZ PHARMACEUTICALS · tablet - 10 S · Rx
₹65
₹6.47 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Vobit 0.3MG Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Use with caution in kidney or liver disease; monitor liver enzymes if advised. Not recommended in inflammatory bowel disease, intestinal obstruction, malabsorption syndromes, or severe digestive disorders. Risk of hypoglycaemia increases when used with insulin or sulfonylureas—carry glucose; treat low sugar with glucose (not sucrose) as carbohydrate absorption is delayed. Seek medical help for severe abdominal symptoms or allergic reactions.